Why was the Empire Wind vessel cancelled nearly complete?
How will Nvidia's UAE approval impact its stock?
What caused the recent Federal Reserve chair candidate narrowing?
Why is New York Attorney General Letitia James indicted?
How is the government shutdown affecting small businesses?
Why are China and the US escalating port fee charges?
What triggered Tesla's latest safety probe on self-driving cars?
GT Biopharma Reports Progresses Phase 1 Trial Of Lead Drug Candidate For Blood Cancers
benzinga.com/news/health-care/25/10/48097298/exclusive-gt-biopharma-reports-progresses-phase-1-trial-of-lead-drug-candidate-for-blood-cancers
Clinical-stage immuno-oncology company GT Biopharma Inc. (NASDAQ:GTBP) announced on Wednesday that enrollment in the dose escalation cohorts of the Phase 1 trial of GTB-3650 for relapsed or refractory CD33-expressing hematologic malignancies is on track.
The company completed the…
This story appeared on benzinga.com, 2025-10-08 12:31:01.